Treatment with pioglitazone induced significant, reversible mitral regurgitation

Research output: Contribution to journalArticlepeer-review

Abstract

There has in recent years been great concern about possible cardiac side effects of thiazolidinediones ( TZDs). We present a case-report of a 60 year-old male who developed significant mitral regurgitation during six months treatment with pioglitazone in parallel with laboratory indications of fluid retention. Echocardiography six months after discontinuation of medication showed regression of mitral regurgitation and the laboratory parameters were also normalized. It is noteworthy that six months treatment with pioglitazone could induce significant valve dysfunction, which was reversible, and this underlines the importance of carefully monitoring patients when placing them on treatment with TZDs.
Original languageEnglish
Article number3 pp
JournalCardiovascular Diabetology
Volume7
Issue number12
DOIs
Publication statusPublished - 2008

Subject classification (UKÄ)

  • Endocrinology and Diabetes
  • Radiology, Nuclear Medicine and Medical Imaging

Fingerprint

Dive into the research topics of 'Treatment with pioglitazone induced significant, reversible mitral regurgitation'. Together they form a unique fingerprint.

Cite this